The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2024
DOI: 10.1080/19768354.2024.2336249
|View full text |Cite
|
Sign up to set email alerts
|

Reprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment

Seung Woo Kim,
Chan Woo Kim,
Young-Ah Moon
et al.

Abstract: The tumor microenvironment comprises both tumor and non-tumor stromal cells, including tumor-associated macrophages (TAMs), endothelial cells, and carcinoma-associated fibroblasts. TAMs, major components of non-tumor stromal cells, play a crucial role in creating an immunosuppressive environment by releasing cytokines, chemokines, growth factors, and immune checkpoint proteins that inhibit T cell activity. During tumors develop, cancer cells release various mediators, including chemokines and metabolites, that… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 190 publications
0
1
0
Order By: Relevance
“…Extracellular vesicles (EVs) are cell-derived membrane vesicles, which include exosomes originating from intraluminal vesicles and microvesicles shed from the plasma membrane (Colombo et al 2014 ; van Niel et al 2018 ). EVs carry various cellular components, including lipids, nucleic acids, and proteins, and upon uptake by their target cells, they can deliver these components, serving as an effective tool of intercellular communication in many physiological and pathological processes (Zaborowski et al 2015 ; Kalluri and LeBleu 2020 ; Kita and Shimomura 2022 ; Kim et al 2024 ). Due to their inherent in vivo delivery capabilities, numerous attempts have been made to utilize EVs as a gene, protein, or drug delivery platform for therapeutic purposes (Wiklander et al 2019 ; Herrmann et al 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…Extracellular vesicles (EVs) are cell-derived membrane vesicles, which include exosomes originating from intraluminal vesicles and microvesicles shed from the plasma membrane (Colombo et al 2014 ; van Niel et al 2018 ). EVs carry various cellular components, including lipids, nucleic acids, and proteins, and upon uptake by their target cells, they can deliver these components, serving as an effective tool of intercellular communication in many physiological and pathological processes (Zaborowski et al 2015 ; Kalluri and LeBleu 2020 ; Kita and Shimomura 2022 ; Kim et al 2024 ). Due to their inherent in vivo delivery capabilities, numerous attempts have been made to utilize EVs as a gene, protein, or drug delivery platform for therapeutic purposes (Wiklander et al 2019 ; Herrmann et al 2021 ).…”
Section: Introductionmentioning
confidence: 99%